Breaking News

WuXi Biologics Completes Biologics Mfg. Facility in Ireland

Designed to adopt both large scale commercial manufacturing using disposable bioreactors and next-gen continuous bioprocessing manufacturing technology

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

WuXi Biologics has completed the weather-tight seal of its biologics drug substance manufacturing facility on the Dundalk Campus in Ireland, marking the start of the company’s global biomanufacturing network. As one of the world’s largest facilities using single-use bioreactors, this “Facility of the Future” began construction in February 2019 and completed the weather-tight seal of its main facility in December 2019. The facility is designed to adopt both large scale ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters